Independently from ovarian steroids, PRL can modulate the epithelial hierarchy and increase progenitor populations, drive development of ductal and alveolar abnormalities, and with time, promote aggressive metastatic ER+ carcinomas. The gene discussed is ESR1; the disease is carcinoma.